Methotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Abstract
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.Keywords
This publication has 9 references indexed in Scilit:
- Rheumatoid NodulesDermatologic Clinics, 2015
- Methotrexate-induced Accelerated Nodulosis in a Patient with Rheumatoid Arthritis and SclerodermaActa Dermato-Venereologica, 2014
- 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.2007
- Accelerated nodulosis during methotrexate therapy in a patient with systemic lupus erythematosus and Jaccoud's arthropathyRheumatology, 2004
- Methotrexate induced accelerated nodulosis.2004
- A Review of Methotrexate‐Induced Accelerated NodulosisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- The HLA-DRB1*0401 Allele and the Development of Methotrexate-Induced Accelerated Rheumatoid NodulosisMedicine, 2001
- HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity.1995
- Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis.Journal of Clinical Investigation, 1992